glp-1 nutrition support plan guide Supporting GLP1 Meds with - Handout A Registered Dietitian's Guide to

Currently, the ADA does not include tirzepatide as part of their agents with cardiorenal benefit [38]

Both compounds produced meaningful waist circumference reductions, but tirzepatide was superior on both endpoints at week 72 [10]

[DOI] [PubMed] [Google Scholar] 118.Zinman B, Gerich J, Buse JB, Lewin A, Schwartz S, Raskin P, Hale PM, Zdravkovic M, Blonde L LEAD-4 Study Investigators

Given that our study aims to evaluate the effects of SGLT2i and GLP-1RA, and considering that these TAU definitions do not include diabetes mellitus treatments that could introduce bias into our results, we have collectively categorized all these variations under the term TAU for consistency in our analysis

2015 Aug;25(3):3017